plix402 lentiviral vector Search Results


95
Addgene inc lentiviral vector plix 402
Lentiviral Vector Plix 402, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plix402+lentiviral+vector/pLIX_402+(Plasmid+%2341394)/pm39494906-269-25-28
Average 95 stars, based on 1 article reviews
lentiviral vector plix 402 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

96
Addgene inc tet on overexpression lentiviral vector plix 402
The role of NRF2 plays in iAs-induced transformation. (A) GSEA data of NRF2 pathway genes comparing prostate organoids (PO) and spheres (PS) derived from primary human prostate epithelial cells (PrEC) and treated with vehicle (PO-V vs. PS-V) or 1 μ M arsenic (PO-As vs. PS-As). (B) Expression of prostate epithelial differentiation genes in 2-dimensional culture PrEC (PrEC-2D) with NRF2 knockdown (shNRF2). Data shown are mean ± SEM ( n = 3 ); * p < 0.05 vs. shRNA control (shLuc). (C) Sphere formation capability of PrEC with NRF2-knockdown, D7PS: day-7 spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (D) Quantification of sphere formation capability of PrEC treated with NRF2-inducer Oltipraz ( 10 μ M ) for 7 d. D7PS: day-7 prostate spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (E) mRNA level of NRF2 gene and NRF2 pathway marker genes. Tet-On NRF2 expression was induced in PrEC spheres by lentivirus. Spheres were culture − / + doxycycline (Dox, 0.5 ug / mL ) for 7 d (Tet-ON-NRF2 PrEC-D7PS) to induce NRF2 <t>overexpression.</t> Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (F) Quantification of sphere formation capability of PrEC with Tet-On overexpression of NRF2. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (G) Soft-agar colony formation assay of RWPE1 with indicated treatment. Note: iAs, inorganic arsenic; shLuc, RWPE1 with shRNA targeting luciferase gene, negative control; shNRF2, RWPE1 with NRF2 knockdown. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc).
Tet On Overexpression Lentiviral Vector Plix 402, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plix402+lentiviral+vector/pCW57%2E1+(Plasmid+%2341393)/pmc07289393-99-5-15
Average 96 stars, based on 1 article reviews
tet on overexpression lentiviral vector plix 402 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

98
Addgene inc second generation lentiviral packing vectors
The role of NRF2 plays in iAs-induced transformation. (A) GSEA data of NRF2 pathway genes comparing prostate organoids (PO) and spheres (PS) derived from primary human prostate epithelial cells (PrEC) and treated with vehicle (PO-V vs. PS-V) or 1 μ M arsenic (PO-As vs. PS-As). (B) Expression of prostate epithelial differentiation genes in 2-dimensional culture PrEC (PrEC-2D) with NRF2 knockdown (shNRF2). Data shown are mean ± SEM ( n = 3 ); * p < 0.05 vs. shRNA control (shLuc). (C) Sphere formation capability of PrEC with NRF2-knockdown, D7PS: day-7 spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (D) Quantification of sphere formation capability of PrEC treated with NRF2-inducer Oltipraz ( 10 μ M ) for 7 d. D7PS: day-7 prostate spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (E) mRNA level of NRF2 gene and NRF2 pathway marker genes. Tet-On NRF2 expression was induced in PrEC spheres by lentivirus. Spheres were culture − / + doxycycline (Dox, 0.5 ug / mL ) for 7 d (Tet-ON-NRF2 PrEC-D7PS) to induce NRF2 <t>overexpression.</t> Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (F) Quantification of sphere formation capability of PrEC with Tet-On overexpression of NRF2. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (G) Soft-agar colony formation assay of RWPE1 with indicated treatment. Note: iAs, inorganic arsenic; shLuc, RWPE1 with shRNA targeting luciferase gene, negative control; shNRF2, RWPE1 with NRF2 knockdown. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc).
Second Generation Lentiviral Packing Vectors, supplied by Addgene inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plix402+lentiviral+vector/psPAX2+(Plasmid+%2312260)/pmc06960293-168-5-15
Average 98 stars, based on 1 article reviews
second generation lentiviral packing vectors - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier

94
Addgene inc ha tag sequences
The role of NRF2 plays in iAs-induced transformation. (A) GSEA data of NRF2 pathway genes comparing prostate organoids (PO) and spheres (PS) derived from primary human prostate epithelial cells (PrEC) and treated with vehicle (PO-V vs. PS-V) or 1 μ M arsenic (PO-As vs. PS-As). (B) Expression of prostate epithelial differentiation genes in 2-dimensional culture PrEC (PrEC-2D) with NRF2 knockdown (shNRF2). Data shown are mean ± SEM ( n = 3 ); * p < 0.05 vs. shRNA control (shLuc). (C) Sphere formation capability of PrEC with NRF2-knockdown, D7PS: day-7 spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (D) Quantification of sphere formation capability of PrEC treated with NRF2-inducer Oltipraz ( 10 μ M ) for 7 d. D7PS: day-7 prostate spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (E) mRNA level of NRF2 gene and NRF2 pathway marker genes. Tet-On NRF2 expression was induced in PrEC spheres by lentivirus. Spheres were culture − / + doxycycline (Dox, 0.5 ug / mL ) for 7 d (Tet-ON-NRF2 PrEC-D7PS) to induce NRF2 <t>overexpression.</t> Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (F) Quantification of sphere formation capability of PrEC with Tet-On overexpression of NRF2. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (G) Soft-agar colony formation assay of RWPE1 with indicated treatment. Note: iAs, inorganic arsenic; shLuc, RWPE1 with shRNA targeting luciferase gene, negative control; shNRF2, RWPE1 with NRF2 knockdown. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc).
Ha Tag Sequences, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plix402+lentiviral+vector/HA-tag+(Plasmid+%2355182)/pmc12282084-204-26-34
Average 94 stars, based on 1 article reviews
ha tag sequences - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

be-m17  (ATCC)
95
ATCC be-m17
The role of NRF2 plays in iAs-induced transformation. (A) GSEA data of NRF2 pathway genes comparing prostate organoids (PO) and spheres (PS) derived from primary human prostate epithelial cells (PrEC) and treated with vehicle (PO-V vs. PS-V) or 1 μ M arsenic (PO-As vs. PS-As). (B) Expression of prostate epithelial differentiation genes in 2-dimensional culture PrEC (PrEC-2D) with NRF2 knockdown (shNRF2). Data shown are mean ± SEM ( n = 3 ); * p < 0.05 vs. shRNA control (shLuc). (C) Sphere formation capability of PrEC with NRF2-knockdown, D7PS: day-7 spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (D) Quantification of sphere formation capability of PrEC treated with NRF2-inducer Oltipraz ( 10 μ M ) for 7 d. D7PS: day-7 prostate spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (E) mRNA level of NRF2 gene and NRF2 pathway marker genes. Tet-On NRF2 expression was induced in PrEC spheres by lentivirus. Spheres were culture − / + doxycycline (Dox, 0.5 ug / mL ) for 7 d (Tet-ON-NRF2 PrEC-D7PS) to induce NRF2 <t>overexpression.</t> Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (F) Quantification of sphere formation capability of PrEC with Tet-On overexpression of NRF2. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (G) Soft-agar colony formation assay of RWPE1 with indicated treatment. Note: iAs, inorganic arsenic; shLuc, RWPE1 with shRNA targeting luciferase gene, negative control; shNRF2, RWPE1 with NRF2 knockdown. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc).
Be M17, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plix402+lentiviral+vector/BE-M17/custom%40crl-2267%4035445353
Average 95 stars, based on 1 article reviews
be-m17 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

96
Addgene inc destination vectors
The role of NRF2 plays in iAs-induced transformation. (A) GSEA data of NRF2 pathway genes comparing prostate organoids (PO) and spheres (PS) derived from primary human prostate epithelial cells (PrEC) and treated with vehicle (PO-V vs. PS-V) or 1 μ M arsenic (PO-As vs. PS-As). (B) Expression of prostate epithelial differentiation genes in 2-dimensional culture PrEC (PrEC-2D) with NRF2 knockdown (shNRF2). Data shown are mean ± SEM ( n = 3 ); * p < 0.05 vs. shRNA control (shLuc). (C) Sphere formation capability of PrEC with NRF2-knockdown, D7PS: day-7 spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (D) Quantification of sphere formation capability of PrEC treated with NRF2-inducer Oltipraz ( 10 μ M ) for 7 d. D7PS: day-7 prostate spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (E) mRNA level of NRF2 gene and NRF2 pathway marker genes. Tet-On NRF2 expression was induced in PrEC spheres by lentivirus. Spheres were culture − / + doxycycline (Dox, 0.5 ug / mL ) for 7 d (Tet-ON-NRF2 PrEC-D7PS) to induce NRF2 <t>overexpression.</t> Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (F) Quantification of sphere formation capability of PrEC with Tet-On overexpression of NRF2. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (G) Soft-agar colony formation assay of RWPE1 with indicated treatment. Note: iAs, inorganic arsenic; shLuc, RWPE1 with shRNA targeting luciferase gene, negative control; shNRF2, RWPE1 with NRF2 knockdown. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc).
Destination Vectors, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plix402+lentiviral+vector/Destination+Vector+(Plasmid+%23125754)/pmc11847143-501-25-23
Average 96 stars, based on 1 article reviews
destination vectors - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

93
Addgene inc a3g sequences
The role of NRF2 plays in iAs-induced transformation. (A) GSEA data of NRF2 pathway genes comparing prostate organoids (PO) and spheres (PS) derived from primary human prostate epithelial cells (PrEC) and treated with vehicle (PO-V vs. PS-V) or 1 μ M arsenic (PO-As vs. PS-As). (B) Expression of prostate epithelial differentiation genes in 2-dimensional culture PrEC (PrEC-2D) with NRF2 knockdown (shNRF2). Data shown are mean ± SEM ( n = 3 ); * p < 0.05 vs. shRNA control (shLuc). (C) Sphere formation capability of PrEC with NRF2-knockdown, D7PS: day-7 spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (D) Quantification of sphere formation capability of PrEC treated with NRF2-inducer Oltipraz ( 10 μ M ) for 7 d. D7PS: day-7 prostate spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (E) mRNA level of NRF2 gene and NRF2 pathway marker genes. Tet-On NRF2 expression was induced in PrEC spheres by lentivirus. Spheres were culture − / + doxycycline (Dox, 0.5 ug / mL ) for 7 d (Tet-ON-NRF2 PrEC-D7PS) to induce NRF2 <t>overexpression.</t> Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (F) Quantification of sphere formation capability of PrEC with Tet-On overexpression of NRF2. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (G) Soft-agar colony formation assay of RWPE1 with indicated treatment. Note: iAs, inorganic arsenic; shLuc, RWPE1 with shRNA targeting luciferase gene, negative control; shNRF2, RWPE1 with NRF2 knockdown. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc).
A3g Sequences, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plix402+lentiviral+vector/APOBEC3G+(Plasmid+%23155413)/pm40470958-274-63-89
Average 93 stars, based on 1 article reviews
a3g sequences - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Addgene inc egfp rab10
The role of NRF2 plays in iAs-induced transformation. (A) GSEA data of NRF2 pathway genes comparing prostate organoids (PO) and spheres (PS) derived from primary human prostate epithelial cells (PrEC) and treated with vehicle (PO-V vs. PS-V) or 1 μ M arsenic (PO-As vs. PS-As). (B) Expression of prostate epithelial differentiation genes in 2-dimensional culture PrEC (PrEC-2D) with NRF2 knockdown (shNRF2). Data shown are mean ± SEM ( n = 3 ); * p < 0.05 vs. shRNA control (shLuc). (C) Sphere formation capability of PrEC with NRF2-knockdown, D7PS: day-7 spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (D) Quantification of sphere formation capability of PrEC treated with NRF2-inducer Oltipraz ( 10 μ M ) for 7 d. D7PS: day-7 prostate spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (E) mRNA level of NRF2 gene and NRF2 pathway marker genes. Tet-On NRF2 expression was induced in PrEC spheres by lentivirus. Spheres were culture − / + doxycycline (Dox, 0.5 ug / mL ) for 7 d (Tet-ON-NRF2 PrEC-D7PS) to induce NRF2 <t>overexpression.</t> Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (F) Quantification of sphere formation capability of PrEC with Tet-On overexpression of NRF2. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (G) Soft-agar colony formation assay of RWPE1 with indicated treatment. Note: iAs, inorganic arsenic; shLuc, RWPE1 with shRNA targeting luciferase gene, negative control; shNRF2, RWPE1 with NRF2 knockdown. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc).
Egfp Rab10, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plix402+lentiviral+vector/EGFP-Rab10+(Plasmid+%2349472)/pmc11760598-113-9-23
Average 93 stars, based on 1 article reviews
egfp rab10 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Addgene inc plx301
The role of NRF2 plays in iAs-induced transformation. (A) GSEA data of NRF2 pathway genes comparing prostate organoids (PO) and spheres (PS) derived from primary human prostate epithelial cells (PrEC) and treated with vehicle (PO-V vs. PS-V) or 1 μ M arsenic (PO-As vs. PS-As). (B) Expression of prostate epithelial differentiation genes in 2-dimensional culture PrEC (PrEC-2D) with NRF2 knockdown (shNRF2). Data shown are mean ± SEM ( n = 3 ); * p < 0.05 vs. shRNA control (shLuc). (C) Sphere formation capability of PrEC with NRF2-knockdown, D7PS: day-7 spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (D) Quantification of sphere formation capability of PrEC treated with NRF2-inducer Oltipraz ( 10 μ M ) for 7 d. D7PS: day-7 prostate spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (E) mRNA level of NRF2 gene and NRF2 pathway marker genes. Tet-On NRF2 expression was induced in PrEC spheres by lentivirus. Spheres were culture − / + doxycycline (Dox, 0.5 ug / mL ) for 7 d (Tet-ON-NRF2 PrEC-D7PS) to induce NRF2 <t>overexpression.</t> Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (F) Quantification of sphere formation capability of PrEC with Tet-On overexpression of NRF2. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (G) Soft-agar colony formation assay of RWPE1 with indicated treatment. Note: iAs, inorganic arsenic; shLuc, RWPE1 with shRNA targeting luciferase gene, negative control; shNRF2, RWPE1 with NRF2 knockdown. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc).
Plx301, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plix402+lentiviral+vector/pLX301+(Plasmid+%2325895)/pmc11656513-63-25-31
Average 93 stars, based on 1 article reviews
plx301 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Addgene inc egfp rab10 q68l
The role of NRF2 plays in iAs-induced transformation. (A) GSEA data of NRF2 pathway genes comparing prostate organoids (PO) and spheres (PS) derived from primary human prostate epithelial cells (PrEC) and treated with vehicle (PO-V vs. PS-V) or 1 μ M arsenic (PO-As vs. PS-As). (B) Expression of prostate epithelial differentiation genes in 2-dimensional culture PrEC (PrEC-2D) with NRF2 knockdown (shNRF2). Data shown are mean ± SEM ( n = 3 ); * p < 0.05 vs. shRNA control (shLuc). (C) Sphere formation capability of PrEC with NRF2-knockdown, D7PS: day-7 spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (D) Quantification of sphere formation capability of PrEC treated with NRF2-inducer Oltipraz ( 10 μ M ) for 7 d. D7PS: day-7 prostate spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (E) mRNA level of NRF2 gene and NRF2 pathway marker genes. Tet-On NRF2 expression was induced in PrEC spheres by lentivirus. Spheres were culture − / + doxycycline (Dox, 0.5 ug / mL ) for 7 d (Tet-ON-NRF2 PrEC-D7PS) to induce NRF2 <t>overexpression.</t> Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (F) Quantification of sphere formation capability of PrEC with Tet-On overexpression of NRF2. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (G) Soft-agar colony formation assay of RWPE1 with indicated treatment. Note: iAs, inorganic arsenic; shLuc, RWPE1 with shRNA targeting luciferase gene, negative control; shNRF2, RWPE1 with NRF2 knockdown. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc).
Egfp Rab10 Q68l, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plix402+lentiviral+vector/EGFP-Rab10Q68L+(Plasmid+%2349544)/pmc11760598-113-13-23
Average 93 stars, based on 1 article reviews
egfp rab10 q68l - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

94
Addgene inc plx303
The role of NRF2 plays in iAs-induced transformation. (A) GSEA data of NRF2 pathway genes comparing prostate organoids (PO) and spheres (PS) derived from primary human prostate epithelial cells (PrEC) and treated with vehicle (PO-V vs. PS-V) or 1 μ M arsenic (PO-As vs. PS-As). (B) Expression of prostate epithelial differentiation genes in 2-dimensional culture PrEC (PrEC-2D) with NRF2 knockdown (shNRF2). Data shown are mean ± SEM ( n = 3 ); * p < 0.05 vs. shRNA control (shLuc). (C) Sphere formation capability of PrEC with NRF2-knockdown, D7PS: day-7 spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (D) Quantification of sphere formation capability of PrEC treated with NRF2-inducer Oltipraz ( 10 μ M ) for 7 d. D7PS: day-7 prostate spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (E) mRNA level of NRF2 gene and NRF2 pathway marker genes. Tet-On NRF2 expression was induced in PrEC spheres by lentivirus. Spheres were culture − / + doxycycline (Dox, 0.5 ug / mL ) for 7 d (Tet-ON-NRF2 PrEC-D7PS) to induce NRF2 <t>overexpression.</t> Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (F) Quantification of sphere formation capability of PrEC with Tet-On overexpression of NRF2. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (G) Soft-agar colony formation assay of RWPE1 with indicated treatment. Note: iAs, inorganic arsenic; shLuc, RWPE1 with shRNA targeting luciferase gene, negative control; shNRF2, RWPE1 with NRF2 knockdown. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc).
Plx303, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plix402+lentiviral+vector/pLX303+(Plasmid+%2325897)/pmc11656513-63-39-45
Average 94 stars, based on 1 article reviews
plx303 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


The role of NRF2 plays in iAs-induced transformation. (A) GSEA data of NRF2 pathway genes comparing prostate organoids (PO) and spheres (PS) derived from primary human prostate epithelial cells (PrEC) and treated with vehicle (PO-V vs. PS-V) or 1 μ M arsenic (PO-As vs. PS-As). (B) Expression of prostate epithelial differentiation genes in 2-dimensional culture PrEC (PrEC-2D) with NRF2 knockdown (shNRF2). Data shown are mean ± SEM ( n = 3 ); * p < 0.05 vs. shRNA control (shLuc). (C) Sphere formation capability of PrEC with NRF2-knockdown, D7PS: day-7 spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (D) Quantification of sphere formation capability of PrEC treated with NRF2-inducer Oltipraz ( 10 μ M ) for 7 d. D7PS: day-7 prostate spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (E) mRNA level of NRF2 gene and NRF2 pathway marker genes. Tet-On NRF2 expression was induced in PrEC spheres by lentivirus. Spheres were culture − / + doxycycline (Dox, 0.5 ug / mL ) for 7 d (Tet-ON-NRF2 PrEC-D7PS) to induce NRF2 overexpression. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (F) Quantification of sphere formation capability of PrEC with Tet-On overexpression of NRF2. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (G) Soft-agar colony formation assay of RWPE1 with indicated treatment. Note: iAs, inorganic arsenic; shLuc, RWPE1 with shRNA targeting luciferase gene, negative control; shNRF2, RWPE1 with NRF2 knockdown. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc).

Journal: Environmental Health Perspectives

Article Title: Effects of Inorganic Arsenic on Human Prostate Stem-Progenitor Cell Transformation, Autophagic Flux Blockade, and NRF2 Pathway Activation

doi: 10.1289/EHP6471

Figure Lengend Snippet: The role of NRF2 plays in iAs-induced transformation. (A) GSEA data of NRF2 pathway genes comparing prostate organoids (PO) and spheres (PS) derived from primary human prostate epithelial cells (PrEC) and treated with vehicle (PO-V vs. PS-V) or 1 μ M arsenic (PO-As vs. PS-As). (B) Expression of prostate epithelial differentiation genes in 2-dimensional culture PrEC (PrEC-2D) with NRF2 knockdown (shNRF2). Data shown are mean ± SEM ( n = 3 ); * p < 0.05 vs. shRNA control (shLuc). (C) Sphere formation capability of PrEC with NRF2-knockdown, D7PS: day-7 spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (D) Quantification of sphere formation capability of PrEC treated with NRF2-inducer Oltipraz ( 10 μ M ) for 7 d. D7PS: day-7 prostate spheres. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (E) mRNA level of NRF2 gene and NRF2 pathway marker genes. Tet-On NRF2 expression was induced in PrEC spheres by lentivirus. Spheres were culture − / + doxycycline (Dox, 0.5 ug / mL ) for 7 d (Tet-ON-NRF2 PrEC-D7PS) to induce NRF2 overexpression. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (F) Quantification of sphere formation capability of PrEC with Tet-On overexpression of NRF2. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (G) Soft-agar colony formation assay of RWPE1 with indicated treatment. Note: iAs, inorganic arsenic; shLuc, RWPE1 with shRNA targeting luciferase gene, negative control; shNRF2, RWPE1 with NRF2 knockdown. Data shown are mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc).

Article Snippet: This was subcloned to a Tet-On overexpression lentiviral vector pLIX_402 (a gift from David Root, Addgene plasmid 41393) with a C-terminal HA tag. mCherry-EGFP-LC3B CDS were subcloned from pBabe-puro mCherry-EGFP-LC3B (a gift from Jayanta Debnath, Addgene plasmid 22418) to pLVX-puro (Clontech; Cat. No. 632164).

Techniques: Transformation Assay, Derivative Assay, Expressing, Knockdown, shRNA, Control, Marker, Over Expression, Soft Agar Assay, Luciferase, Negative Control

Arsenic effects on lysosome acidification and expression of V-ATPase subunit VMA5. (A) LysoHunt staining showing acidification of organelles from day-4 spheres of primary human prostate epithelial cells (PrEC-D4PS) cultured on low-attached plate with indicated treatment. Higher intensity of red signal from LysoHunt indicates higher acidification. BafA1, bafilomycin A1, V-ATPase inhibitor, 100 nM treatment for 2 h; iAs, 1 μ M iAs treatment for 4 d; Veh, vehicle. Quantification data are mean ± SEM ( n = 10 – 13 spheres from wells of same low-attach plate); * p < 0.05 vs. vehicle. (B) mRNA level of VMA5 gene in D7PS of RWPE1 and PrEC treated with 1 μ M iAs for 7 d. Mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (C) Immunoblot of VMA5 protein in PrEC-D7PS treated with 1 μ M iAs for 7 d. Mean ± SEM ( n = 3 ); * p < 0.05 vs. vehicle. (D) mRNA level of VMA5 in PrEC with shRNA targeting VMA5 (shVMA5). Mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc). (E) LysoHunt staining showing acidification of organelles from day-4 spheres of primary human prostate epithelial cells (PrEC-D4PS) with VMA5 gene knockdown (shVMA5). Quantitative data are mean ± SEM ( n = 10 – 15 ); * p < 0.05 vs. shRNA control (shLuc). (F) Immunoblotting of p62 and LC3B from PrEC-D7PS with VMA5 gene knockdown (shVMA5). Mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc). (G) Immunoblot of indicated protein in PrEC-D7PS with Tet-On VMA5 overexpression treated with 1 μ M iAs for 7 d. Doxycycline (Dox, 0.5 ug / mL ) was added to induce VMA5 overexpression for 7 d. Quantification data are mean ± SEM ( n = 3 ); * p < 0.05 vs. vehicle control.

Journal: Environmental Health Perspectives

Article Title: Effects of Inorganic Arsenic on Human Prostate Stem-Progenitor Cell Transformation, Autophagic Flux Blockade, and NRF2 Pathway Activation

doi: 10.1289/EHP6471

Figure Lengend Snippet: Arsenic effects on lysosome acidification and expression of V-ATPase subunit VMA5. (A) LysoHunt staining showing acidification of organelles from day-4 spheres of primary human prostate epithelial cells (PrEC-D4PS) cultured on low-attached plate with indicated treatment. Higher intensity of red signal from LysoHunt indicates higher acidification. BafA1, bafilomycin A1, V-ATPase inhibitor, 100 nM treatment for 2 h; iAs, 1 μ M iAs treatment for 4 d; Veh, vehicle. Quantification data are mean ± SEM ( n = 10 – 13 spheres from wells of same low-attach plate); * p < 0.05 vs. vehicle. (B) mRNA level of VMA5 gene in D7PS of RWPE1 and PrEC treated with 1 μ M iAs for 7 d. Mean ± SEM ( n = 4 ); * p < 0.05 vs. vehicle. (C) Immunoblot of VMA5 protein in PrEC-D7PS treated with 1 μ M iAs for 7 d. Mean ± SEM ( n = 3 ); * p < 0.05 vs. vehicle. (D) mRNA level of VMA5 in PrEC with shRNA targeting VMA5 (shVMA5). Mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc). (E) LysoHunt staining showing acidification of organelles from day-4 spheres of primary human prostate epithelial cells (PrEC-D4PS) with VMA5 gene knockdown (shVMA5). Quantitative data are mean ± SEM ( n = 10 – 15 ); * p < 0.05 vs. shRNA control (shLuc). (F) Immunoblotting of p62 and LC3B from PrEC-D7PS with VMA5 gene knockdown (shVMA5). Mean ± SEM ( n = 4 ); * p < 0.05 vs. shRNA control (shLuc). (G) Immunoblot of indicated protein in PrEC-D7PS with Tet-On VMA5 overexpression treated with 1 μ M iAs for 7 d. Doxycycline (Dox, 0.5 ug / mL ) was added to induce VMA5 overexpression for 7 d. Quantification data are mean ± SEM ( n = 3 ); * p < 0.05 vs. vehicle control.

Article Snippet: This was subcloned to a Tet-On overexpression lentiviral vector pLIX_402 (a gift from David Root, Addgene plasmid 41393) with a C-terminal HA tag. mCherry-EGFP-LC3B CDS were subcloned from pBabe-puro mCherry-EGFP-LC3B (a gift from Jayanta Debnath, Addgene plasmid 22418) to pLVX-puro (Clontech; Cat. No. 632164).

Techniques: Expressing, Staining, Cell Culture, Western Blot, shRNA, Control, Knockdown, Over Expression